Transcriptome-wide association study of Alzheimer disease reveals many differentially expressed genes and multiple biological pathways in brain tissue from African American donors

Mark Logue,Adam Labadorf,Nicholas K O'Niell,Dennis W Dickson,Brittany N Dugger,Margaret E Flanagan,Matthew P Frosch,Marla Gearing,Lee-Way Jin,Julia Kofler,Richard Mayeux,Ann McKee,Carol A Miller,Melissa E Murray,Peter T Nelson,Richard J E Perrin,Julie A Schneider,Thor D Stein,Andrew Teich,Juan C Tronsco,Shih-Hsiu Wang,Benjamin Wolozin,Jesse Mez,Lindsay A Farrer
DOI: https://doi.org/10.1101/2024.10.29.24316311
2024-11-04
Abstract:Background: The genetic basis of Alzheimer disease (AD) in African American (AA) individuals is much less well understood than in European-ancestry (EA) individuals. Furthermore, relatively few AA donors have been included in postmortem AD studies. Methods: We generated transcriptome-wide bulk-level gene expression data derived from pre-frontal cortex (PFC) tissue obtained from 179 AA brain donors with a pathological diagnosis of AD or control. This sample was augmented by previously generated RNAseq data derived from PFC tissue from another group of 28 AA donors, yielding a total sample of 125 AD cases and 82 neuropathologically determined controls who were enrolled at 12 AD research centers across the United States. Expression of 33,611 genes was compared between AD cases and controls using LIMMA including covariates for age, sex, cell-type frequencies, and RNA integrity number. A false discovery rate corrected p-value (padj) was used to account for multiple testing. Gene-ontology (GO) term enrichment analysis was performed using GOseq. Results: Transcriptome-wide significant differential expression was observed with 482 genes among which the most significant, ADAMTS2, showed 1.52 times higher expression in AD cases compared to controls (p=2.96x10-8, padj=0.0010). Many of the differentially expressed genes are involved in mitochondrial energy production. Examination of differentially expressed genes observed previously in brain tissue from EA AD cases and controls revealed that 385 (35%) were nominally significant, 65 (5.8%) were significant after multiple test correction, and most (89%) had the same effect direction in the AA sample. Several other significant associations were not observed in the EA cohort, and these genes may be especially relevant to AD risk in the AA population (e.g., EFR3B, IRS4, and CA12). Examination of potential regulatory effects of AA GWAS-implicated AD risk variants identified several expression quantitative trait loci. Conclusions: In this first large-scale transcriptome-wide gene expression study of AD in brain from AA donors, we identified many differentially expressed genes, including ADAMTS2 which was recently reported to be differentially expressed in brain between pathologically confirmed EA AD cases with and without AD clinical symptoms. These results represent a substantial advance in knowledge about the genetic basis of AD in the AA population and suggest promising new targets for treatment.
What problem does this paper attempt to address?
This paper aims to explore the genetic basis of Alzheimer's Disease (AD) in the African American (AA) population. Specifically, through a Transcriptome - wide Association Study (TWAS), the researchers analyzed prefrontal cortex tissue samples from 179 African Americans, of which 125 were pathologically confirmed AD patients and 82 were in the control group. The main objectives of the study were: 1. **Identify differentially expressed genes**: By comparing the gene expression levels between AD patients and the control group, identify genes that are significantly differentially expressed in AD patients. 2. **Explore biological pathways**: Analyze the biological pathways in which these differentially expressed genes are involved to reveal the potential molecular mechanisms of AD in African Americans. 3. **Cross - ethnic comparison**: Compare the identified differentially expressed genes with the relevant research results in European - Ancestry (EA) Americans to evaluate the consistency of the expression patterns and effect directions of these genes in different ethnic backgrounds. 4. **Identify expression quantitative trait loci (eQTLs)**: Explore the effects of known AD risk variants on gene expression, especially those risk variants found in African Americans. ### Main findings - **Differentially expressed genes**: The study found 482 genes that were significantly differentially expressed between AD patients and the control group. The most significant one was ADAMTS2, whose expression level in AD patients was 1.52 times higher than that in the control group (log2 fold change = 0.60, p = 2.96 × 10^-8, adjusted p - value = 0.0010). - **Biological pathways**: The differentially expressed genes were mainly enriched in biological pathways related to mitochondrial energy production, redox processes, phosphorylation, DNA binding, and transcriptional regulation. - **Cross - ethnic consistency**: In the studies of European - Ancestry Americans, 385 (35%) of the differentially expressed genes also showed nominal significance in African Americans, and 65 (5.8%) remained significant after multiple - test correction, and most (89%) of the genes had the same effect direction in both ethnic groups. - **eQTLs**: The study also found several expression quantitative trait loci related to AD risk variants. For example, two highly correlated SNPs (rs2234253 and rs73427293) in the TREM2/TREML2 region were associated with increased expression of ADCY10P1 and TREML2. ### Conclusion This study is the largest AD Transcriptome - wide Association Study on African - American brain tissue to date. The study not only identified multiple genes that were significantly differentially expressed in AD patients but also revealed the key biological pathways in which these genes were involved. In addition, the study also found expression quantitative trait loci related to AD risk variants, providing important clues for further understanding the genetic basis and potential therapeutic targets of AD. These findings are of great significance for the development of AD treatment methods for specific ethnic backgrounds.